The antenatal sildenafil STRIDER trial for severe fetal growth restriction, are post hoc reflections ad rem?

Francesca M. Russo; Felix R. De Bie; Emily A. Partridge; Karel Allegaert; Jan Deprest

doi:10.1007/s00431-022-04569-7

The antenatal sildenafil STRIDER trial for severe fetal growth restriction, are post hoc reflections ad rem?

Francesca M. Russo^*, Felix R. De Bie, Emily A. Partridge, Karel Allegaert, Jan Deprest

^*Corresponding author for this work

Pharmacy

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	3775-3776
Number of pages	2
Journal	European Journal of Pediatrics
Volume	181
Issue number	10
Early online date	26 Jul 2022
DOIs	https://doi.org/10.1007/s00431-022-04569-7
Publication status	Published - Oct 2022

Access to Document

10.1007/s00431-022-04569-7Licence: Unspecified

Cite this

@article{67fa745e2c484c7eb164c175b5a29257,

title = "The antenatal sildenafil STRIDER trial for severe fetal growth restriction, are post hoc reflections ad rem?",

author = "Russo, {Francesca M.} and {De Bie}, {Felix R.} and Partridge, {Emily A.} and Karel Allegaert and Jan Deprest",

year = "2022",

month = oct,

doi = "10.1007/s00431-022-04569-7",

language = "English",

volume = "181",

pages = "3775--3776",

journal = "European Journal of Pediatrics",

issn = "0340-6199",